-Wayne W Hancock Researcher Activity Profile

Research Author Detailed Information 

Wayne W Hancock Publication Rate By Year

Wayne W Hancock has published 1 paper(s) in 1998, 3 paper(s) in 2006, 14 paper(s) in 2007, 1 paper(s) in 2008, for a total of 19 research publications in total.

Wayne W Ww Hancock Author Information

LAST NAME: hancock

FIRST NAME: Wayne W

INITIALS: ww

AFFILIATION:

Papers

Wayne W Hancock's Publication Record

1. Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease. Year Published: 2007
Department of Molecular Biology and Biochemistry, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
2. Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. Year Published: 2006
Transplantation Research Center, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA. william.harmon@childrens.harvard.edu
3. The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade. Year Published: 2006
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
4. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. Year Published: 2006
Joseph Stokes, Jr. Research Institute, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
5. Regulating regulatory T cells to achieve transplant tolerance. Year Published: 2007
Division of Transplantation Immunology, Department of Pathology and Laboratory Medicine, Joseph Stokes, Jr., Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA. taor@upmc.edu
6. Biochemistry and therapeutic implications of mechanisms involved in FOXP3 activity in immune suppression. Year Published: 2007
Department of Pathology and Laboratory Medicine, University of Pennsylvania, 252 John Morgan Building, 36th and Hamilton Walk, Philadelphia, PA 19104-6082, USA.
7. Histone deacetylase inhibitors and transplantation. Year Published: 2007
Division of Transplant Immunology, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104-4318, USA.
8. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance. Year Published: 2007
Department of Pathology and Laboratory Medicine, Joseph Stokes Jr Research Institute and Biesecker Pediatric Liver Center, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA 19104-4318, USA.
9. Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival. Year Published: 2007
The Surgical Medical Research Institute, Department of Surgery, Faculty of Medicine, The University of Alberta, Edmonton, Alberta, Canada.
10. Combined Coinhibitory and Costimulatory Modulation with Anti-BTLA and CTLA4Ig Facilitates Tolerance in Murine Islet Allografts. Year Published: 2007
The Surgical Medical Research Institute, Department of Surgery, Faculty of Medicine, The University of Alberta, Edmonton, Alberta, Canada.
11. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts. Year Published: 2007
The Surgical Medical Research Institute, Department of Surgery, Faculty of Medicine, The University of Alberta, Edmonton, Alberta, Canada.
12. Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival. Year Published: 2007
The Surgical Medical Research Institute, Department of Surgery, Faculty of Medicine, The University of Alberta, Edmonton, Alberta, Canada.
13. Biochemistry and therapeutic implications of mechanisms involved in FOXP3 activity in immune suppression. Year Published: 2007
Department of Pathology and Laboratory Medicine, University of Pennsylvania, 252 John Morgan Building, 36th and Hamilton Walk, Philadelphia, PA 19104-6082, USA.
14. Histone deacetylase inhibitors and transplantation. Year Published: 2007
Division of Transplant Immunology, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104-4318, USA.
15. Impact of alloimmunity on chronic tissue remodelling: role of cytokines and protective genes in the vessel wall. Year Published: 1998
Department of Pathology, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, Massachusetts, USA. wayne_hancock@leukosite.com
16. Deacetylase inhibition promotes the generation and function of regulatory T cells. Year Published: 2007
Division of Transplantation Immunology, Department of Pathology and Laboratory Medicine and Biesecker Center for Studies of Pediatric Liver Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4318, USA.
17. Deacetylase inhibition promotes the generation and function of regulatory T cells. Year Published: 2007
Division of Transplantation Immunology, Department of Pathology and Laboratory Medicine and Biesecker Center for Studies of Pediatric Liver Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4318, USA.
18. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts. Year Published: 2007
The Surgical Medical Research Institute, Department of Surgery, Faculty of Medicine, The University of Alberta, Edmonton, Alberta, Canada.
19. Effects of Histone Deacetylase Inhibitor SAHA on Effector and FOXP3+Regulatory T Cells in Rhesus Macaques. Year Published: 2008
Diabetes Institute for Immunology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.